Pre-orders Of COVID-19 Vaccine Top Five Billion
Fahad Shabbir (@FahadShabbir) Published August 11, 2020 | 11:00 PM
Washington, (UrduPoint / Pakistan Point News - 11th Aug, 2020 ) :Although none of the coronavirus vaccines under development has proved its efficacy yet in clinical trials, at least 5.7 billion doses have been pre-ordered around the world.
First shipments of a COVID-19 vaccine created by Western laboratories have often been snapped up by the United States.
Five vaccines -- three Western and two Chinese -- are in Phase 3 efficacy trials involving thousands of people.
In a surprise announcement, Russian President Vladimir Putin claimed Tuesday that a vaccine dubbed "Sputnik V" -- after the Soviet satellite -- conferred "sustainable immunity" against the novel coronavirus.
As research laboratories around the world race to develop a vaccine, manufacturers have received financing to help them prepare to have millions of doses ready to administer in 2021 or even before the end of the year.
Oxford University, working with the Swedish-British pharmaceutical group AstraZeneca, hopes to have results by September while the US biotech company Moderna, partnering with the US National Institutes of Health (NIH), is aiming for the end of the year, possibly November.
- US: 700 million doses - President Donald Trump has launched "Operation Warp Speed" in a bid to develop, manufacture and distribute a COVID-19 vaccine to all Americans by January 2021.
Hundreds of millions of Dollars have been directed to vaccine developers including nearly $500 million to Johnson & Johnson at the end of March.
The United States has allocated funding to more companies than other nation in the hope that one of them will come up with the vaccine to counter the highly contagious virus.
So far, Washington has handed out at a total of least 9.4 billion dollars to seven vaccine developers and signed manufacturing contracts with five of them to provide 700 million doses.
The companies involved are: Johnson & Johnson, Moderna, Oxford/AztraZeneca, Novavax, Pfizer/BioNTech, Sanofi/GSK, Merck Sharp and Dohme.
- Europe: 700 million doses Two vaccine developers -- Oxford/AztraZeneca and Sanofi/GSK -- have signed or are in advanced negotiations with the European Commission to provide a combined 700 million vaccine doses.
Related Topics
Recent Stories
Pakistan marks World Press Freedom Day
High-level Saudi business delegation due on May 5
Stocks heat up as US labour market cools
President approves Tax Laws (Amendment) Bill 2024
Implementation of merit, justice to oppressed segments top priorities: CPO
Overseas Kashmir community delegation calls on AJK President, discusses latest s ..
Govt believes in freedom of press: Amir Muqam
Labour urges UK election after Tory losses
Health authorities asked for action against alleged illegal tenders at Services ..
Spain scraps national bullfighting prize sparking debate
Lahore High Court (LHC) Chief Justice Malik Shahzad Ahmad Khan visits Rawalpindi ..
ATC extends interim bail of PTI founder in 3 cases
More Stories From Miscellaneous
-
Waste Management – A persistent challenge for MWMC
21 hours ago -
Experts for ending child labour
3 days ago -
Labour Day - A reminder for better facilities to workers
3 days ago -
Stage Drama Mohabati Manhoon presents in Arts council Larkana
5 days ago -
Wheat farmers in a fix on price, procurement mechanism
6 days ago -
Modern tools to help transform crime investigation procedures
6 days ago
-
Sanam Marvi captivates audience with mesmerizing performance
7 days ago -
Modern Education Techniques: A pathway to achieve economic development
8 days ago -
Kite Flying: From cultural festival to deadly sport
8 days ago -
PDMA predicts gusty wind, rain with thunder, hails
10 days ago -
Iranian president Raisi given guard of honour at PM House
12 days ago -
Intellectuals, writers accolades Naseer Mirza on his literary contribution
12 days ago